Literature DB >> 11237847

Sporadic Campylobacter jejuni infections in Hawaii: associations with prior antibiotic use and commercially prepared chicken.

P Effler1, M C Ieong, A Kimura, M Nakata, R Burr, E Cremer, L Slutsker.   

Abstract

Campylobacter is the most common cause of bacterial foodborne illness in the United States, and Hawaii has the highest rate of Campylobacter jejuni infections in the nation. A case-control study was conducted to determine indigenous exposures that contribute to the high incidence of sporadic C. jejuni infection in Hawaii. A total of 211 case patients with diarrhea and confirmed Campylobacter infection was enrolled, along with 1 age- and telephone exchange-matched control subject for each patient. Participants were interviewed about illness, medicines, food consumption, food-handling practices, and exposure to animals. In matched logistic regression analyses, eating chicken prepared by a commercial food establishment in the 7 days before case illness onset (adjusted odds ratio [AOR], 1.8; P=.03) and consuming antibiotics during the 28 days before illness onset (AOR, 3.3; P=.03) were significant independent predictors of illness. Further study of the association of Campylobacter illness with commercially prepared chicken and prior antibiotic use is needed.

Entities:  

Mesh:

Year:  2001        PMID: 11237847     DOI: 10.1086/319292

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  24 in total

1.  Temperature dependence of reported Campylobacter infection in England, 1989-1999.

Authors:  C C Tam; L C Rodrigues; S J O'Brien; S Hajat
Journal:  Epidemiol Infect       Date:  2006-02       Impact factor: 2.451

2.  Demographic determinants for Campylobacter infection in England and Wales: implications for future epidemiological studies.

Authors:  I A Gillespie; S J O'Brien; C Penman; D Tompkins; J Cowden; T J Humphrey
Journal:  Epidemiol Infect       Date:  2008-12       Impact factor: 2.451

3.  A multi-centre prospective case-control study of campylobacter infection in persons aged 5 years and older in Australia.

Authors:  Cameron Moffatt
Journal:  Epidemiol Infect       Date:  2008-04-15       Impact factor: 2.451

4.  Risk factors for infection with Campylobacter jejuni flaA genotypes.

Authors:  L E Unicomb; L C O'Reilly; M D Kirk; R J Stafford; H V Smith; N G Becker; M S Patel; G L Gilbert
Journal:  Epidemiol Infect       Date:  2008-01-21       Impact factor: 2.451

5.  [A technic using MRI. A comparative study of 3 anesthetic technics of the inferior alveolar nerve].

Authors:  P Libersa; S Dujardin; J P Francke; J C Libersa; B Pertuzon
Journal:  Bull Group Int Rech Sci Stomatol Odontol       Date:  1999 Oct-Dec

Review 6.  Foodborne illness: new developments concerning an old problem.

Authors:  Eric J Kasowski; Gary D Gackstetter; Trueman W Sharp
Journal:  Curr Gastroenterol Rep       Date:  2002-08

7.  Antimicrobial resistance and antimicrobial use associated with laboratory-confirmed cases of Campylobacter infection in two health units in Ontario.

Authors:  Anne E Deckert; Richard J Reid-Smith; Susan E Tamblyn; Larry Morrell; Patrick Seliske; Frances B Jamieson; Rebecca Irwin; Catherine E Dewey; Patrick Boerlin; Scott A McEwen
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

8.  Population-attributable risk estimates for Campylobacter infection, Australia.

Authors:  Iain Gillespie
Journal:  Emerg Infect Dis       Date:  2009-05       Impact factor: 6.883

9.  A case-case comparison of Campylobacter coli and Campylobacter jejuni infection: a tool for generating hypotheses.

Authors:  Iain A Gillespie; Sarah J O'Brien; Jennifer A Frost; Goutam K Adak; Peter Horby; Anthony V Swan; Michael J Painter; Keith R Neal
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

10.  Chicken consumption and use of acid-suppressing medications as risk factors for Campylobacter enteritis, England.

Authors:  Clarence C Tam; Craig D Higgins; Keith R Neal; Laura C Rodrigues; Sally E Millership; Sarah J O'Brien
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.